We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cronobacter Sakazakii Isolation Kits Reduce Need for Subculture and Confirmatory Tests

By LabMedica International staff writers
Posted on 06 Oct 2009
A range of microbiologic media has been developed that provides a choice of products to meet all the recognized requirements for the culture and isolation of Cronobacter sakazakii.

The products will be a major focus at Medica 2009, held November 18-21, 2009, in Düsseldorf, Germany. More...
Lab M's (Bury, Lancashire, UK) expanding Harlequin brand chromogenic media, which includes two of the three C. sakazakii products, will also be on display. In addition, there will be the first news of selected products launching in 2010.

A foodborne pathogen, C. sakazakii, is associated with sporadic cases and outbreaks of meningitis, necrotizing enterocolitis, and sepsis, particularly in newborns. The three key media for its isolation and identification are all available from Lab M and meet the need for simplified methods of testing: Harlequin CSIM--Cronobacter sakazakii Isolation Medium (ISO); CSEB--Cronobacter sakazakii enrichment broth (ISO); and Harlequin CSA-DFI (differential fluorescence induction)--Cronobacter sakazakii agar-DFI formulation.

Harlequin CSA-DFI--Cronobacter sakazakii agar--DFI formulation is one of the most recent additions to Lab M's Harlequin range of chromogenic media. Developed to improve the isolation and identification of a variety of microorganisms, Harlequin media can help reduce the need for subculture and confirmatory biochemical tests. The range also includes media for Listeria monocytogenes isolation, the enumeration of coliforms, and Escherichia coli O157:H7, and Salmonella species isolation.

Lab M specializes in the development and production of microbiologic diagnostic products.

Related Links:
Lab M


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Genai-based pathological assessment workflow for lung adenocarcinoma (Shen J. et al., Int J Surg 111(7): 4252–4262; 2025)

Generative AI Demonstrates Expert-Level Pathological Assessment of Lung Cancer

Lung adenocarcinoma is one of the most difficult cancers to diagnose accurately, requiring pathologists to spend extensive time examining tissue samples under microscopes to determine tumor grades and... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.